Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Lucia Benedetto"'
Autor:
Stefania Scalise, Clara Zannino, Valeria Lucchino, Michela Lo Conte, Vittorio Abbonante, Giorgia Lucia Benedetto, Mariangela Scalise, Antonio Gambardella, Elvira Immacolata Parrotta, Giovanni Cuda
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-15 (2024)
Abstract Prolonged febrile seizures (FS) in children are linked to the development of temporal lobe epilepsy (MTLE). The association between these two pathologies may be ascribed to the long-term effects that FS exert on neural stem cells, negatively
Externí odkaz:
https://doaj.org/article/312ac296e2f2429caa9049a45606b587
Autor:
Valeria Lucchino, Luana Scaramuzzino, Stefania Scalise, Michela Lo Conte, Clara Zannino, Giorgia Lucia Benedetto, Umberto Aguglia, Edoardo Ferlazzo, Giovanni Cuda, Elvira Immacolata Parrotta
Publikováno v:
Cells, Vol 11, Iss 21, p 3491 (2022)
Unverricht-Lundborg disease (ULD), also known as progressive myoclonic epilepsy 1 (EPM1), is a rare autosomal recessive neurodegenerative disorder characterized by a complex symptomatology that includes action- and stimulus-sensitive myoclonus and to
Externí odkaz:
https://doaj.org/article/6d6a8c7fef864716addbdb6e971790c6
Publikováno v:
Assistenza infermieristica e ricerca : AIR. 39(1)
The contribution of voluntary associations in the process of eliminating mechanical restraint in hospitals.Eliminating the restraint use in fragile people at any age and pathological condition is an ethical, legal, deontological commitment.To describ
Autor:
Ketty Peris, Rosachiara Forcignanò, Lucia Benedetto, Vincenzo De Giorgi, Maria Teresa Corradin, Paola Queirolo, Giuseppe Giudice, Francesco Spagnolo, Antonella Vecchiato, Paolo A. Ascierto, Sara Gandini, Alessandro Testori, Carlo Riccardo Rossi, Fabrizio Ayala, Giusto Trevisan, Guido Zannetti, Giovanni Borroni, Giulio Tosti, Maurizio Montella
Publikováno v:
Oncology Letters
Previous studies have reported an association between sun exposure and the increased survival of patients with cutaneous melanoma (CM). The present study analyzed the association between ultraviolet (UV) light exposure and various prognostic factors
Autor:
P.A. Ascierto, Marialina Tornesello, G. Di Monta, Nicola Mozzillo, Ugo Marone, Corrado Caracò, Ester Simeone, Lucia Benedetto, Franco M. Buonaguro, S. La Padula
Publikováno v:
European Journal of Surgical Oncology (EJSO). 40:61-66
Background Electrochemotherapy (ECT) is a novel modality for the treatment of skin nodules and cutaneous or subcutaneous tumors that allows delivery of low and non-permeant drug into cells. The aim of this prospective single-center study was to evalu
Autor:
Nicola Mozzillo, Gerardo Botti, Maria Luisa Di Cecilia, Ugo Marone, Corrado Caracò, Gianluca Di Monta, Lucia Benedetto, Ester Simeone, Paolo A. Ascierto
Publikováno v:
BMC Cancer
Background Treatment of early and multiple cutaneous unresectable recurrences is a major therapeutic problem with around 80% of patients relapsing within 5 years. For lesions refractory to elective treatments, electrochemotherapy (ECT) involving elec
Publikováno v:
European Journal of Surgical Oncology (EJSO). 42:S212
Autor:
Ester Simeone, Paolo A. Ascierto, Diana Giannarelli, Marcello Curvietto, Lucia Benedetto, Rosa Camerlingo, Mariaelena Capone, Nicola Mozzillo, Ugo Marone, Corrado Caracò, Antonio M. Grimaldi, Gabriele Madonna, Gennaro Ciliberto, Gianluca Di Monta, Massimiliano Di Marzo, Stefano Mori, Giusy Gentilcore, Lucia Festino
Publikováno v:
ResearcherID
Oncoimmunology
Oncoimmunology
Melanoma is responsible for most skin cancer-related deaths and is one of the most common cancers diagnosed in young adults. In melanoma, tumors can become established by activation of the negative regulator of cytotoxic T lymphocytes (CTLs), CTL ant
Autor:
Stefano Mori, Gianluca Di Monta, Ugo Marone, Maria Luisa Di Cecilia, Corrado Caracò, Gerardo Botti, Lucia Benedetto, Paolo A. Ascierto, Ester Simeone, Massimiliano Di Marzo, Nicola Mozzillo
Publikováno v:
Journal of Translational Medicine
Background Treatment of early and multiple cutaneous unresectable recurrences is a major therapeutic problem with around 80% of patients relapsing within 5 years [1]. For lesions refractory to elective treatments, electrochemotherapy (ECT) involving
Autor:
Stefano Mori, Ugo Marone, Corrado Caracò, Marialuisa Di Cecilia, Giusy Gentilcore, Nicola Mozzillo, Antonio M. Grimaldi, Gianluca Di Monta, Ester Simeone, Paolo A. Ascierto, M. Capone, Lucia Benedetto
Publikováno v:
Journal of Translational Medicine
Background Ipilimumab is the first agent approved for the treatment of advanced melanoma that showed a survival benefit in randomized phase 3 trials. Despite the survival benefit, due to its mechanism of action it is associated with a slow onset and